Free tool

Cell therapy stocks

We cover 15 companies grouped under the Cell therapy theme. The median market value in the group is $43.15M. Across the group, the median move over the past trading day is 0.00%. Price change over the past year runs from −75.9% to −3.7% across the middle 80 percent of the group, with a median of −24.4%.

Other lists in this group

Table

15 of 86 companies match these filters.Clear filters

TickerCompanyMarket cap (USD)Size1Y return
7776.TCellSeed Inc.$56.74MMicro cap−47.42%
4896.TK Pharma,Inc.$56.45MMicro cap+15.89%
4584.TKidswell Bio Corporation$55.83MMicro cap−24.37%
ALA.AXArovella Therapeutics Limited$52.84MMicro cap−26.19%
7096.TStemCell Institute Inc.$48.78MMicro cap−21.54%
2370.TMEDINET Co., Ltd.$44.25MMicro cap−34.21%
3750.TADR Biomedical Holdings Inc.$43.59MMicro cap−15.61%
4880.TCellSource Co., Ltd.$43.15MMicro cap−41.78%
4893.TNoile-Immune Biotech Inc.$40.36MMicro cap−17.32%
4892.TCyfuse Biomedical K.K.$36.02MMicro cap−9.22%
311A.TNPT Co Ltd$20.81MMicro cap−43.33%
CMB.AXCambium Bio Limited$8.86MMicro cap0.00%
1AD.AXAdAlta Limited$6.90MMicro cap−12.50%
CYP.AXCynata Therapeutics Limited$1.92MMicro cap−94.88%
CHM.AXChimeric Therapeutics Limited$659.83KMicro cap−95.67%

Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.

More ways to browse